CD163 and hydrops fetalis: Consequently, CD163, FPR1, and VSIG4 were selected for ROC analysis, which revealed that the AUC for all three biomarkers exceeded 0.7 in both datasets, confirming their potential as HF biomarkers (Figures 4c-h).